US Biotechs Capture $37.2B of Global $54.5B VC Funding Since 2025

U.S. biopharma firms raised $37.2B since 2025 — 68% of the world's $54.5B total — with the Bay Area and Boston absorbing 62% of American capital, per J.P. Morgan.